Annual Cash & Cash Equivalents
$131.54 M
-$41.80 M-24.11%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual cash & cash equivalents is $131.54 million, with the most recent change of -$41.80 million (-24.11%) on December 31, 2023.
- During the last 3 years, ACHL annual cash & cash equivalents has fallen by -$46.31 million (-26.04%).
- ACHL annual cash & cash equivalents is now -50.61% below its all-time high of $266.32 million, reached on December 31, 2021.
Performance
ACHL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$86.05 M
-$9.06 M-9.52%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly cash and cash equivalents is $86.05 million, with the most recent change of -$9.06 million (-9.52%) on September 1, 2024.
- Over the past year, ACHL quarterly cash and cash equivalents has dropped by -$45.49 million (-34.58%).
- ACHL quarterly cash and cash equivalents is now -71.25% below its all-time high of $299.32 million, reached on June 30, 2021.
Performance
ACHL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACHL Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.1% | -34.6% |
3 y3 years | -26.0% | -52.2% |
5 y5 years | +34.8% | -52.2% |
ACHL Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -50.6% | at low | -67.7% | at low |
5 y | 5-year | -50.6% | +34.8% | -71.3% | at low |
alltime | all time | -50.6% | +34.8% | -71.3% | at low |
Achilles Therapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $86.05 M(-9.5%) |
Jun 2024 | - | $95.11 M(-15.3%) |
Mar 2024 | - | $112.32 M(-14.6%) |
Dec 2023 | $131.54 M(-24.1%) | $131.54 M(-6.1%) |
Sep 2023 | - | $140.14 M(-2.5%) |
Jun 2023 | - | $143.71 M(-9.3%) |
Mar 2023 | - | $158.46 M(-8.6%) |
Dec 2022 | $173.34 M | $173.34 M(-3.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $179.89 M(-10.8%) |
Jun 2022 | - | $201.59 M(-14.9%) |
Mar 2022 | - | $236.93 M(-11.0%) |
Dec 2021 | $266.32 M(+49.7%) | $266.32 M(-5.5%) |
Sep 2021 | - | $281.88 M(-5.8%) |
Jun 2021 | - | $299.32 M(+87.9%) |
Mar 2021 | - | $159.26 M(-10.5%) |
Dec 2020 | $177.85 M(+82.2%) | $177.85 M |
Dec 2019 | $97.59 M | - |
FAQ
- What is Achilles Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Achilles Therapeutics?
- What is Achilles Therapeutics annual cash & cash equivalents year-on-year change?
- What is Achilles Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Achilles Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ACHL is $131.54 M
What is the all time high annual cash & cash equivalents for Achilles Therapeutics?
Achilles Therapeutics all-time high annual cash & cash equivalents is $266.32 M
What is Achilles Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ACHL annual cash & cash equivalents has changed by -$41.80 M (-24.11%)
What is Achilles Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACHL is $86.05 M
What is the all time high quarterly cash and cash equivalents for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly cash and cash equivalents is $299.32 M
What is Achilles Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ACHL quarterly cash and cash equivalents has changed by -$45.49 M (-34.58%)